Hosted on MSN3m
Why Is Billionaire Prem Watsa Bullish on Merck & Co., Inc. (MRK) Now?
We recently compiled a list of the Billionaire Prem Watsa's Top 15 Long-Term Stock Picks. In this article, we are going to ...
Merck, Eisai's combination drug fails in late-stage trial for esophageal cancer
Merck and Eisai said on Friday a combination of their cancer therapies failed to extend the lives of patients with a type of ...
Live Cell Imaging Market Report 2025, with Competitor Profiles of Top 10+ Major Market Players
The "Live Cell Imaging Market by Product, By Application, By Technology, By End-User, and By Region" report has been added to ...
Merck KGaA says high asset prices call for prudent M&A approach
The CEO of Germany's Merck KGaA said a recovery in sales growth at its existing business means it can take a cautious approach when it comes to buying other companies, which are expensively priced.
Gene Transfer Technologies Market to Hit US$5.93 Billion by 2029 with 9.7% CAGR | MarketsandMarkets
The global gene transfer technologies market, valued at US$3.63 billion in 2023, is forecasted to grow at a robust CAGR of 9.7%, reaching US$3.73 ...
Jefferies Reaffirms Their Buy Rating on Merck & Company (MRK)
In a report released on January 21, Akash Tewari from Jefferies reiterated a Buy rating on Merck & Company (MRK – Research Report). The ...
Jefferies Keeps Their Buy Rating on Pfizer (PFE)
In a report released on January 21, Akash Tewari from Jefferies reiterated a Buy rating on Pfizer (PFE – Research Report). The company’s shares ...